Emerging roles of protein kinase D1 in cancer

Molecular Cancer Research

Volumn 9, Issue 8, 2011, Pages 985-996

  Sundram, Vasudha ^a   Chauhan, Subhash C ^a,b   Jaggi, Meena ^a,b  

^a SANFORD RESEARCH   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANDROGEN RECEPTOR; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE D; PROTEIN KINASE D1; UNCLASSIFIED DRUG;

BREAST CANCER; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; DIGESTIVE SYSTEM CANCER; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME STRUCTURE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER;

APOPTOSIS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASMS; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 80051986980     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0365     Document Type: Review

References (78)

1. Jaggi M., Du C., Zhang W., Balaji K.C. Protein kinase D1: A protein of emerging translational interest. Front Biosci 2007;12:3757-3767
2. Johannes F.J., Prestle J., Eis S., Oberhagemann P., Pfizenmaier K. PKCu is a novel, atypical member of the protein kinase C family. J Biol Chem 1994;269:6140-6148 (Pubitemid 24243002)
3. Valverde A.M., Sinnett-Smith J., Van Lint J., Rozengurt E. Molecular cloning and characterization of protein kinase D: A target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc Natl Acad Sci USA 1994;91:8572-8576 (Pubitemid 24273706)
4. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002;298:1912-1934 (Pubitemid 35425239)
5. Rozengurt E., Rey O., Waldron R.T. Protein kinase D signaling. J Biol Chem 2005;280:13205-13208 (Pubitemid 40517202)
6. Van Lint J., Rykx A., Maeda Y., Vantus T., Sturany S., Malhotra V., et al. Protein kinase D: An intracellular traffic regulator on the move. Trends Cell Biol 2002;12:193-200. (Pubitemid 34442242)
7. Rykx A., De Kimpe L., Mikhalap S., Vantus T., Seufferlein T., Vandenheede J.R., et al. Protein kinase D: A family affair. FEBS Lett 2003;546:81-86 (Pubitemid 36782285)
8. Guha S., Tanasanvimon S., Sinnett-Smith J., Rozengurt E. Role of protein kinase D signaling in pancreatic cancer. Biochem Pharmacol 2010;80:1946-1954
9. LaValle C.R., George K.M., Sharlow E.R., Lazo J.S., Wipf P., Wang QJ. Protein kinase D as a potential new target for cancer therapy. Biochim Biophys Acta 2010;1806:183-92.
10. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004;101:6062-6067 (Pubitemid 38520528)
11. + (salt taste)-induced learning. Sci Signal 2009;2:ra42.
12. Avkiran M., Rowland A.J., Cuello F., Haworth R.S. Protein kinase d in the cardiovascular system: Emerging roles in health and disease. Circ Res 2008;102:157-163 (Pubitemid 351651119)
13. Murphy T.R., Legere H.J. 3rd, Katz H.R. Activation of protein kinase D1 in mast cells in response to innate, adaptive, and growth factor signals. J Immunol 2007;179:7876-7882
14. Hao Q., Wang L., Tang H. Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells. Am J Physiol Cell Physiol 2009;296:C821-C827
15. UniProt Consortium. Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res 2011;39[Database issue]: D214-9.
16. Sánchez-Ruiloba L., Cabrera-Poch N., Rodríguez- Martínez M., López-Menéndez C., Jean-Mairet R.M., Higuero A.M., et al. Protein kinase D intracellular localization and activity control kinase D-interacting substrate of 220-kDa traffic through a postsynaptic density-95/discs large/zonula occludens-1-binding motif. J Biol Chem 2006;281:18888-18900 (Pubitemid 44035548)
17. Kunkel M.T., Garcia E.L., Kajimoto T., Hall R.A., Newton A.C. The protein scaffold NHERF-1 controls the amplitude and duration of localized protein kinase D activity. J Biol Chem 2009;284:24653-24661
18. Hutti J.E., Jarrell E.T., Chang J.D., Abbott D.W., Storz P., Toker A., et al. A rapid method for determining protein kinase phosphorylation specificity. Nat Methods 2004;1:27-29
19. Nishikawa K., Toker A., Johannes F.J., Songyang Z., Cantley L.C. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem 1997;272:952-960 (Pubitemid 27034586)
20. Döppler H., Storz P., Li J., Comb M.J., Toker A. A phosphorylation statespecific antibody recognizes Hsp27, a novel substrate of protein kinase D. J Biol Chem 2005;280:15013-15019 (Pubitemid 40562854)
21. Auer A., Von Blume J., Sturany S., Von Wichert G., Van Lint J., Vandenheede J., et al. Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling. Mol Biol Cell 2005;16:4375-4385 (Pubitemid 41262904)
22. Rey O., Yuan J., Young S.H., Rozengurt E. Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists. J Biol Chem 2003;278:23773-23785 (Pubitemid 36830202)
23. Bisbal M., Conde C., Donoso M., Bollati F., Sesma J., Quiroga S., et al. Protein kinase d regulates trafficking of dendritic membrane proteins in developing neurons. J Neurosci 2008;28:9297-9308
24. Cowell C.F., Döppler H., Yan I.K., Hausser A., Umezawa Y., Storz P. Mitochondrial diacylglycerol initiates protein-kinase D1-mediated ROS signaling. J Cell Sci 2009;122:919-928
25. Storz P. Mitochondrial ROS - radical detoxification, mediated by protein kinase D. Trends Cell Biol 2007;17:13-18 (Pubitemid 46028964)
26. Hurd C., Rozengurt E. Uncoupling of protein kinase D from suppression of EGF-dependent c-Jun phosphorylation in cancer cells. Biochem Biophys Res Commun 2003;302:800-804 (Pubitemid 36294044)
27. Jacamo R., Sinnett-Smith J., Rey O., Waldron R.T., Rozengurt E. Sequential protein kinase C (PKC)-dependent and PKC-independent protein kinase D catalytic activation via Gq-coupled receptors: Differential regulation of activation loop Ser(744) and Ser(748) phosphorylation. J Biol Chem 2008;283:12877-12887
28. Rybin V.O., Guo J., Steinberg S.F. Protein kinase D1 autophosphorylation via distinct mechanisms at Ser744/Ser748 and Ser916. J Biol Chem 2009;284:2332-2343
29. Vertommen D., Rider M., Ni Y., Waelkens E., Merlevede W., Vandenheede J.R., et al. Regulation of protein kinase D by multisite phosphorylation. Identification of phosphorylation sites by mass spectrometry and characterization by site-directed mutagenesis. J Biol Chem 2000;275:19567-19576 (Pubitemid 30441550)
30. Rozengurt E. Mitogenic signaling pathways induced by G proteincoupled receptors. J Cell Physiol 2007;213:589-602. (Pubitemid 350058250)
31. Wagner E.F., Nebreda A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009;9:537-549
32. Trauzold A., Schmiedel S., Sipos B., Wermann H., Westphal S., Röder C., et al. PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene 2003;22:8939-8947 (Pubitemid 38021510)
33. Kisfalvi K., Hurd C., Guha S., Rozengurt E. Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells. J Cell Physiol 2010;223:309-316
34. Brenner W., Beitz S., Schneider E., Benzing F., Unger R.E., Roos F.C., et al. Adhesion of renal carcinoma cells to endothelial cells depends on PKCmu. BMC Cancer 2010;10:183.
35. Storz P., Toker A. Protein kinase D mediates a stress-induced NFkappaB activation and survival pathway. EMBO J 2003;22:109-120 (Pubitemid 36091274)
36. Isaacs J.T., Isaacs W.B. Androgen receptor outwits prostate cancer drugs. Nat Med 2004;10:26-27 (Pubitemid 38524693)
37. Mak P., Jaggi M., Syed V., Chauhan S.C., Hassan S., Biswas H., et al. Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells. Biochem Biophys Res Commun 2008;373:618-623
38. Hassan S., Biswas M.H., Zhang C., Du C., Balaji K.C. Heat shock protein 27 mediates repression of androgen receptor function by protein kinase D1 in prostate cancer cells. Oncogene 2009;28:4386-4396
39. Wang G., Wang J., Sadar M.D. Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer. Cancer Res 2008;68:9918-9927
40. Jaggi M., Johansson S.L., Baker J.J., Smith L.M., Galich A., Balaji K.C. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urol Oncol 2005;23:402-406 (Pubitemid 41654506)
41. Jaggi M., Rao P.S., Smith D.J., Hemstreet G.P., Balaji K.C. Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem Biophys Res Commun 2003;307:254-260 (Pubitemid 36818862)
42. Jaggi M., Chauhan S.C., Du C., Balaji K.C. Bryostatin 1 modulates betacatenin subcellular localization and transcription activity through protein kinase D1 activation. Mol Cancer Ther 2008;7:2703-2712
43. Müller S., Krämer O.H. Inhibitors of HDACs - effective drugs against cancer? Curr Cancer Drug Targets 2010;10:210-228
44. Ha C.H., Wang W., Jhun B.S., Wong C., Hausser A., Pfizenmaier K., et al. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis. J Biol Chem 2008;283:14590-14599
45. Ha C.H., Jhun B.S., Kao H.Y., Jin Z.G. VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis. Arterioscler Thromb Vasc Biol 2008;28:1782-1788
46. Watkins J.L., Lewandowski K.T., Meek S.E., Storz P., Toker A., Piwnica-Worms H. Phosphorylation of the Par-1 polarity kinase by protein kinase D regulates 14-3-3 binding and membrane association. Proc Natl Acad Sci USA 2008;105:18378-18383
47. Jaggi M., Rao P.S., Smith D.J., Wheelock M.J., Johnson K.R., Hemstreet G.P., et al. E-cadherin phosphorylation by protein kinase D1/protein kinase Cmu is associated with altered cellular aggregation and motility in prostate cancer. Cancer Res 2005;65:483-492
48. Yamamoto H., Oue N., Sato A., Hasegawa Y., Yamamoto H., Matsubara A., et al. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 2010;29:2036-2046
49. Woods A.J., White D.P., Caswell P.T., Norman J.C. PKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. EMBO J 2004;23:2531-2543 (Pubitemid 38988225)
50. Eiseler T., Schmid M.A., Topbas F., Pfizenmaier K., Hausser A. PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration. FEBS Lett 2007;581:4279-4287 (Pubitemid 47301866)
51. Syed V., Mak P., Du C., Balaji K.C. Beta-catenin mediates alteration in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E-cadherin and protein kinase D1. J Cell Biochem 2008;104:82-95.
52. Eiseler T., Döppler H., Yan I.K., Goodison S., Storz P. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res 2009;11:R13.
53. Storz P. Protein kinase D1: A novel regulator of actin-driven directed cell migration. Cell Cycle 2009;8:1975-1976
54. Peterburs P., Heering J., Link G., Pfizenmaier K., Olayioye M.A., Hausser A. Protein kinase D regulates cell migration by direct phosphorylation of the cofilin phosphatase slingshot 1 like. Cancer Res 2009;69:5634-5638
55. Eiseler T., Döppler H., Yan I.K., Kitatani K., Mizuno K., Storz P. Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot. Nat Cell Biol 2009;11:545-556
56. Eiseler T., Hausser A., De Kimpe L., Van Lint J., Pfizenmaier K. Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin. J Biol Chem 2010;285:18672-18683
57. De Kimpe L., Janssens K., Derua R., Armacki M., Goicoechea S., Otey C., et al. Characterization of cortactin as an in vivo protein kinase D substrate: Interdependence of sites and potentiation by Src. Cell Signal 2009;21:253-263
58. Du C., Jaggi M., Zhang C., Balaji K.C. Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin. Cancer Res 2009;69:1117-1124
59. Kim M., Jang H.R., Kim J.H., Noh S.M., Song K.S., Cho J.S., et al. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Carcinogenesis 2008;29:629-637 (Pubitemid 351404881)
60. Jepperson T., Hughes J., Hausser A., Balaji K., Chauhan S., Jaggi M. Protein kinase D1 reduces cellular proliferation and invasiveness via suppression of beta-catenin/T-cell factor activity in SW480 colon cancer cells [abstract 4256]. In: Proceedings of the 100th Annual Meeting of the American Association for Cancer Research; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009.
61. Guha S., Rey O., Rozengurt E. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Res 2002;62:1632-1640 (Pubitemid 34408482)
62. Bollag W.B., Dodd M.E., Shapiro B.A. Protein kinase D and keratinocyte proliferation. Drug News Perspect 2004;17:117-126 (Pubitemid 38568409)
63. Ristich V.L., Bowman P.H., Dodd M.E., Bollag W.B. Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis. Br J Dermatol 2006;154:586-593 (Pubitemid 43374080)
64. Wu C., Orozco C., Boyer J., Leglise M., Goodale J., Batalov S., et al. BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009;10:R130.
65. Du C., Zhang C., Hassan S., Biswas M.H., Balaji K.C. Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail. Cancer Res 2010;70:7810-7819
66. Biswas M.H., Du C., Zhang C., Straubhaar J., Languino L.R., Balaji K.C. Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer. Cancer Res 2010;70:2095-2104
67. Rao P.S., Jaggi M., Smith D.J., Hemstreet G.P., Balaji KC. Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer. Biochem Biophys Res Commun 2003;310:1032-1038
68. Smith D.J., Jaggi M., Zhang W., Galich A., Du C., Sterrett S.P., et al. Metallothioneins and resistance to cisplatin and radiation in prostate cancer. Urology 2006;67:1341-1347 (Pubitemid 43818081)
69. Lavalle C.R., Bravo-Altamirano K., Giridhar K.V., Chen J., Sharlow E., Lazo J.S., et al. Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility. BMC Chem Biol 2010;10:5.
70. Chen J., Deng F., Singh S.V., Wang Q.J. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res 2008;68:3844-3853
71. Bowden E.T., Barth M., Thomas D., Glazer R.I., Mueller S.C. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999;18:4440-4449 (Pubitemid 29396652)
72. Rodriguez Perez C.N., Nie W., Sinnett-Smith J., Rozengurt E., Yoo J. TNF-alpha potentiates lysophosphatidic acid-induced COX-2 expression via PKD in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2011;300:G637-G646
73. Guha S., Lunn J.A., Santiskulvong C., Rozengurt E. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Cancer Res 2003;63:2379-2387 (Pubitemid 36605172)
74. Harikumar K.B., Kunnumakkara A.B., Ochi N., Tong Z., Deorukhkar A., Sung B., et al. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther 2010;9:1136-1146Erratum in Mol Cancer Ther 2010;9:2153.
75. Jadali A., Ghazizadeh S. Protein kinase D is implicated in the reversible commitment to differentiation in primary cultures of mouse keratinocytes. J Biol Chem 2010;285:23387-23397
76. Arun S.N., Kaddour-Djebbar I., Shapiro B.A., Bollag W.B. Ultraviolet B irradiation and activation of protein kinase D in primary mouse epidermal keratinocytes. Oncogene 2010;30:1586-1596
77. Paolucci L., Rozengurt E. Protein kinase D in small cell lung cancer cells: Rapid activation through protein kinase C. Cancer Res 1999;59:572-577 (Pubitemid 29076052)
78. Yuan J., Rozengurt E. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells. J Cell Biochem 2008;103:648-662 (Pubitemid 351171935)